Tiny study tests if cognitive stimulation therapy can reverse frailty after stroke

NCT ID NCT06733103

Completed Knowledge-focused Sponsor: University of East Anglia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether an adapted version of cognitive stimulation therapy (CST) is acceptable and feasible for stroke survivors who are pre-frail. Ten stroke survivors and their carers took part in focus groups to share their experiences. The goal was to see if CST could be a useful part of a future multicomponent frailty intervention for stroke survivors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Adapted cognitive stimulation therapy (CST)
What this could lead to: If successful, this could pave the way for a larger trial testing whether CST helps reverse pre-frailty in stroke survivors.
What could go wrong: This is a very small pilot study with only 10 participants, so results may not apply widely. The therapy is adapted from dementia care and has not been tested in stroke populations before.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARERS FRAILTY STROKE

Contacts and locations

Locations

Cambridge University Hospitals NHS Foundation Trust

Cambridge, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.